In cardiovascular disorders, including hypertension, RhoGEFs could be considered as key molecules involved in the hyperactivity of RhoA (Cario‐Toumaniantz et al., 2012; Loirand et al., 2008; Strassheim et al., 2019). Here, RHOA is linked to hypertensive disorder.